PPARδ and Intestinal Tumorigenesis in Mice
Author Information
Author(s): Karen R. Reed, Owen J. Sansom, Anthony J. Hayes, Andreas J. Gescher, Jeffrey M. Peters, Alan R. Clarke
Primary Institution: Cardiff School of Biosciences, Cardiff University
Hypothesis
Does PPARδ deficiency affect intestinal neoplasia in mice with impaired mismatch repair?
Conclusion
PPARδ deficiency does not alter the incidence or morphology of intestinal tumors in mice with defective mismatch repair.
Supporting Evidence
- No significant differences in tumor incidence were found between control and double mutant genotypes.
- PPARδ deficiency does not enhance or diminish the mutator phenotype associated with mismatch repair deficiency.
- The study suggests that PPARδ's role in tumorigenesis is context-dependent.
Takeaway
The study found that removing a gene called PPARδ doesn't change how many tumors mice get when they have a problem fixing their DNA.
Methodology
Mice with PPARδ and mismatch repair gene deficiencies were inter-crossed, and tumor incidence and severity were recorded.
Limitations
The study may not detect subtle effects of PPARδ deficiency due to small cohort sizes.
Participant Demographics
Mice were C57BL 6 backcrossed with specific genetic modifications.
Statistical Information
P-Value
0.34
Statistical Significance
p = 0.34
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website